Bryan Larsen

3.1k total citations
109 papers, 2.3k citations indexed

About

Bryan Larsen is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Bryan Larsen has authored 109 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 32 papers in Microbiology and 27 papers in Infectious Diseases. Recurrent topics in Bryan Larsen's work include Reproductive tract infections research (31 papers), Antifungal resistance and susceptibility (24 papers) and Urinary Tract Infections Management (20 papers). Bryan Larsen is often cited by papers focused on Reproductive tract infections research (31 papers), Antifungal resistance and susceptibility (24 papers) and Urinary Tract Infections Management (20 papers). Bryan Larsen collaborates with scholars based in United States, Italy and Denmark. Bryan Larsen's co-authors include Rudolph P. Galask, Gilles R.G. Monif, Michael Essmann, Joseph Hwang, A. J. Markovetz, Douglas D. Glover, Paulo César Giraldo, Paul R. Summers, Iara M. Linhares and Steven S. Witkin and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Bryan Larsen

105 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan Larsen United States 27 989 782 476 469 344 109 2.3k
Werner Mendling Germany 26 1.4k 1.5× 1.8k 2.3× 466 1.0× 561 1.2× 264 0.8× 92 2.8k
Mary L. Delaney United States 22 924 0.9× 935 1.2× 527 1.1× 1.2k 2.5× 293 0.9× 34 2.7k
Sebastian Faro United States 23 794 0.8× 857 1.1× 139 0.3× 406 0.9× 323 0.9× 97 1.8k
Antonella Marangoni Italy 25 794 0.8× 1.2k 1.6× 381 0.8× 571 1.2× 208 0.6× 116 2.3k
Ran Nir‐Paz Israel 27 869 0.9× 606 0.8× 449 0.9× 382 0.8× 235 0.7× 98 2.2k
C S Easmon United Kingdom 24 673 0.7× 684 0.9× 491 1.0× 352 0.8× 459 1.3× 109 2.3k
Catharina Svanborg Edén Sweden 29 2.0k 2.0× 288 0.4× 390 0.8× 861 1.8× 142 0.4× 66 3.8k
D. M. MacLaren Netherlands 29 673 0.7× 555 0.7× 504 1.1× 662 1.4× 196 0.6× 104 2.8k
Hiroshi Watanabe Japan 23 668 0.7× 329 0.4× 475 1.0× 417 0.9× 153 0.4× 131 1.8k
Dan Danielsson Sweden 30 1.0k 1.0× 1.3k 1.7× 272 0.6× 430 0.9× 257 0.7× 160 3.1k

Countries citing papers authored by Bryan Larsen

Since Specialization
Citations

This map shows the geographic impact of Bryan Larsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Larsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Larsen more than expected).

Fields of papers citing papers by Bryan Larsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Larsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Larsen. The network helps show where Bryan Larsen may publish in the future.

Co-authorship network of co-authors of Bryan Larsen

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Larsen. A scholar is included among the top collaborators of Bryan Larsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Larsen. Bryan Larsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seta, Francesco De, et al.. (2021). Rational development and evaluation of novel formulations for urinary health. European Journal of Obstetrics & Gynecology and Reproductive Biology. 269. 90–97.
2.
Larsen, Bryan, et al.. (2020). Navigating the Third Frontier of Antimicrobial Therapy to Support Women’s Health. Open Journal of Obstetrics and Gynecology. 10(8). 1011–1035. 1 indexed citations
3.
Larsen, Bryan, Marija Petrović, & Francesco De Seta. (2017). Boric Acid and Commercial Organoboron Products as Inhibitors of Drug-Resistant Candida albicans. Mycopathologia. 183(2). 349–357. 11 indexed citations
4.
Essmann, Michael, et al.. (2010). Quantitative real time PCR detection of Clostridium difficile growth inhibition by probiotic organisms.. Europe PMC (PubMed Central). 8 indexed citations
5.
Seta, Francesco De, Martin Schmidt, Benoît Ly Vu, Michael Essmann, & Bryan Larsen. (2008). Antifungal mechanisms supporting boric acid therapy of Candida vaginitis. Journal of Antimicrobial Chemotherapy. 63(2). 325–336. 101 indexed citations
6.
Larsen, Bryan, et al.. (2006). Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. Yeast. 23(11). 795–802. 25 indexed citations
7.
Essmann, Michael, et al.. (2006). Adherence and Blocking of Candida Albicans to Cultured Vaginal Epithelial Cells: Treatments to Decrease Adherence. Infectious Diseases in Obstetrics and Gynecology. 2006(1). 98218–98218. 11 indexed citations
8.
Essmann, Michael, et al.. (2004). Surface Modifying Substances that Reduce Apparent Yeast Cell Hydrophobicity. Infectious Diseases in Obstetrics and Gynecology. 13(3). 171–177. 5 indexed citations
9.
Smith, Jennifer M., et al.. (2001). Differences in Innate Immunologic Response to Group BStreptococcus Between Colonized and Noncolonized Women. Infectious Diseases in Obstetrics and Gynecology. 9(3). 125–132. 2 indexed citations
10.
Yazdanyar, Ali, Michael Essmann, & Bryan Larsen. (2001). Genistein effects on growth and cell cycle ofCandida albicans. Journal of Biomedical Science. 8(2). 153–159. 12 indexed citations
11.
Larsen, Bryan & Douglas D. Glover. (1998). Serum erythromycin levels in pregnancy. Clinical Therapeutics. 20(5). 971–977. 2 indexed citations
12.
Engle, Jacquelyn T., et al.. (1998). Effect of gliotoxin on human polymorphonuclear neutrophils. Infectious Diseases in Obstetrics and Gynecology. 6(4). 168–175. 27 indexed citations
13.
White, Susan A. & Bryan Larsen. (1997). Candida albicans morphogenesis is influenced by estrogen. Cellular and Molecular Life Sciences. 53(9). 744–749. 54 indexed citations
14.
Glover, Douglas D., et al.. (1995). In situ Mycotoxin Production byCandidaalbicansin Women with Vaginitis. Gynecologic and Obstetric Investigation. 39(1). 67–69. 32 indexed citations
15.
Larsen, Bryan. (1994). Virulence Attributes of Low‐Virulence Organisms. Infectious Diseases in Obstetrics and Gynecology. 2(2). 95–104. 2 indexed citations
16.
Larsen, Bryan. (1993). Vaginal Flora in Health and Disease. Clinical Obstetrics & Gynecology. 36(1). 107–121. 92 indexed citations
17.
Stanek, Ronald J., et al.. (1992). High performance ion exclusion chromatographic characterization of the vaginal organic acids in women with bacterial vaginosis. Biomedical Chromatography. 6(5). 231–235. 17 indexed citations
18.
Larsen, Bryan, et al.. (1991). Clinical isolates of yeast produce a gliotoxin-like substance. Mycopathologia. 116(3). 203–208. 47 indexed citations
19.
Larsen, Bryan, B. R. Davis, & David Charles. (1984). Critical Assessment of Antibacterial Properties of Human Amniotic Fluid. Gynecologic and Obstetric Investigation. 18(2). 100–104. 13 indexed citations
20.
Larsen, Bryan & N. A. Lassen. (1979). Regulation of cerebral blood flow in health and disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 25. 7–22. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Werner Mendling Breakdown of academic impact, for papers by Mary L. Delaney Breakdown of academic impact, for papers by Sebastian Faro Breakdown of academic impact, for papers by Antonella Marangoni Breakdown of academic impact, for papers by Ran Nir‐Paz Breakdown of academic impact, for papers by C S Easmon Breakdown of academic impact, for papers by Catharina Svanborg Edén Breakdown of academic impact, for papers by D. M. MacLaren Breakdown of academic impact, for papers by Hiroshi Watanabe Breakdown of academic impact, for papers by Dan Danielsson
Rankless by CCL
2026